Concerted deletions eliminate a neutralizing supersite in SARS-CoV-2 BA.2.87.1 spike.
Duyvesteyn HME. et al, (2024), Structure (London, England : 1993), 32, 1594 - 1602.e6
Immunogenicity of Abdala COVID-19 vaccine in Vietnamese people after primary and booster vaccinations: A prospective observational study in Vietnam
Thanh TT. et al, (2024), International Journal of Infectious Diseases, 147, 107173 - 107173
Oligomerization-driven avidity correlates with SARS-CoV-2 cellular binding and inhibition
(2024), Proceedings of the National Academy of Sciences, 121
Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers
Suwarti S. et al, (2024), BMC Infectious Diseases, 24
The effect of pH on the structure of Bluetongue virus VP5.
Zhang H. et al, (2024), The Journal of general virology, 105
The impact of exchanging the light and heavy chains on the structures of bovine ultralong antibodies
Clarke JD. et al, (2024), Acta Crystallographica Section F Structural Biology Communications, 80, 154 - 163
Improving the representativeness of UK’s national COVID-19 Infection Survey through spatio-temporal regression and post-stratification
Pouwels KB. et al, (2024), Nature Communications, 15
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity
Liu C. et al, (2024), Cell Reports Medicine, 5, 101553 - 101553
Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium
Nhu LNT. et al, (2024), Wellcome Open Research, 9, 181 - 181
Author Correction: Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses
Michael BD. et al, (2024), Nature Communications, 15
Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection.
Liu C. et al, (2024), Nature communications, 15
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86.
Zhou D. et al, (2024), Nature communications, 15
Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population
Wei J. et al, (2024), Nature Communications, 15
Emerging Enterovirus A71 Subgenogroup B5 Causing Severe Hand, Foot, and Mouth Disease, Vietnam, 2023
Chau NVV. et al, (2024), Emerging Infectious Diseases, 30
Persistence of SARS-CoV-2 antibodies over 18 months following infection: UK Biobank COVID-19 Serology Study
Bešević J. et al, (2024), Journal of Epidemiology and Community Health, 78, 105 - 108
Delayed mucosal anti-viral responses despite robust peripheral inflammation in fatal COVID-19.
Sidhu JK. et al, (2023), The Journal of infectious diseases
Experimental phasing opportunities for macromolecular crystallography at very long wavelengths.
El Omari K. et al, (2023), Commun Chem, 6
ChAdOx1 COVID vaccines express RBD open prefusion SARS-CoV-2 spikes on the cell surface.
Ni T. et al, (2023), iScience, 26
Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera.
Roper KJ. et al, (2023), Scientific reports, 13